Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan“), is pleased to announce that it has received notice from the FDA that Innocan’s …
InnoCan Pharma Corporation (CNSX: INNO) (FSE: IP4), is pleased to announce its collaboration with Recipharm, Israel to synthesize and analyze cannabinoid loaded exosomes. Recipharm unites …
Calgary, Alberta–(Newsfile Corp. – July 2, 2020) – Innocan Pharma Corporation (CNSX: INNO) (FSE: IP4) (the “Company” or “Innocan“) announced today that Mr. Bill Macdonald …
Herzeliya, Israel and Calgary, Alberta–(Newsfile Corp. – June 26, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan”), is pleased to …
Innocan Pharma Corporation (CNSX: INNO) (FSE: IP4) (the “Company” or “Innocan“), is pleased to announce that Mackie Research Capital Corporation’s institutional sales group has issued …
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 16, 2020 (GLOBE NEWSWIRE) — Water Ways Technologies Inc. (TSXV: WWT) (“Water Ways” …
Water Ways Technologies Inc. (TSXV: WWT) (“Water Ways” or the “Company“) reports today its financial and business results for the three months ended March 31, …
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATESCANADA HOUSE WELLNESS GROUP ANNOUNCES AGREEMENT WITH THE SOCIÉTÉ QUÉBÉCOISE DU CANNABIS AND …
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) is pleased to announce the closing of its marketed short form prospectus offering pursuant to which the Company …
